Seattle biotech firm Shape Therapeutics inks gene therapy deal with Roche worth up to $3B by Charlotte Schubert on August 24, 2021August 24, 2021 at 10:06 am Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s and Parkinson’s disease, the Seattle company announced… Read More